Content specific to this active ingredient… Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Drug Recalls For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… Innohep (tinzaparin sodium) Injection, Bristol-Myers Squibb Pharma Company NDA 20-484/S-002 2/5/02 4/17/02 Innohep (tinzaparin sodium) Injection, Dupont Pharmaceutical Company NDA 20-484 7/14/00 7/24/00 7/24/00 4/9/02 Innohep Indications: for the treatment of acute symptomatic deep vein thrombosis with or without pulmonary embolism when administered in conjunction with warfarin sodium. | Innohep (tinzaparin sodium injection), Pharmion, Labeling Revision ^ FDA's latest approval appears at the bottom of this list. ^   A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | News Feed for each API | DMF Index | Pharma Job Search | Pharma Company News © 2008 Betterchem.com